Reduce Incidence of Pre-Dialysis Hyperkalaemia with Sodium Zirconium Cyclosilicate in Chinese Subjects

Trial Identifier: D9485C00001
Sponsor: AstraZeneca
NCTID:: NCT04217590
Start Date: November 2020
Primary Completion Date: January 2022
Study Completion Date: January 2022
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Chinese Translation

Trial Locations

Country Location
CN Baotou, CN, 014040
CN Baotou, CN, 14010
CN beijing, CN, 100191
CN Beijing, CN, 102206
CN Beijing, CN, 100044
CN Beijing, CN, 100029
CN changchun, CN, 130021
CN Changchun, CN, 130041
CN Dongguan, CN, 523009
CN guangzhou, CN, 510080
CN Hangzhou, CN, 310014
CN Hefei, CN, 230001
CN Hohhot, CN, 010017
CN jinan, CN, 250014
CN Lanzhou, CN, 730000
CN Lanzhou, CN, 730030
CN Nanchang, CN, 330006
CN nanjing, CN, 210011
CN nanjing, CN, 211112
CN Ningbo, CN, 315000
CN Ningbo, CN, 315010
CN shanghai, CN, 200232
CN shanghai, CN, 200090
CN shanghai, CN, 200120
CN Shanghai, CN, 200127
CN Shanghai, CN, 201199
CN Shanghai, CN, 200080
CN Shanghai, CN, 200240
CN Shanghai, CN, 200065
CN Shanghai, CN, 200233
CN Shenzhen, CN, 518035
CN Shenzhen, CN, 518053
CN Tianjin, CN, 300052
CN Urumchi, CN, 830054
CN Urumqi, CN, CN-830004
CN wenzhou, CN, 325000
CN Wenzhou, CN, 325027
CN Yangzhou, CN, 225001
CN Yinchuan, CN, 750004